The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment

Diabetes

Volumn 57, Issue 5, 2008, Pages 1312-1320

  Martinuzzi, Emanuela ^a,b   Novelli, Giulia ^c   Scotto, Matthieu ^a,b   Blancou, Philippe ^d   Bach, Jean Marie ^d   Chaillous, Lucy ^d,e   Bruno, Graziella ^c   Chatenoud, Lucienne ^a,b   Van Endert, Peter ^a,b,f   Mallone, Roberto ^a,b,g  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITÉ DE NANTES   (France)

^e HÔTEL DIEU   (France)

^f HÔPITAL SAINT VINCENT DE PAUL   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; GAMMA INTERFERON; GLUCOSE 6 PHOSPHATASE; GLUTAMATE DECARBOXYLASE; HLA A2 ANTIGEN; INSULIN; PREPROINSULIN; PROTEIN; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CATALYSIS; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OUTCOME ASSESSMENT; PANCREAS ISLET CELL; PRIORITY JOURNAL; ANIMAL; COXSACKIE VIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; IMMUNOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; REGULATORY T LYMPHOCYTE;

ADOLESCENT; ADULT; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; EPITOPES; GLUCOSE-6-PHOSPHATASE; GLUTAMATE DECARBOXYLASE; HLA-A2 ANTIGEN; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; PROTEIN PRECURSORS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 48449084868     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1594     Document Type: Article

References (50)

1. Wong FS, Janeway CA Jr: The role of CD4 vs. CD8 T cells in IDDM. J Autoimmun 13:290-295, 1999
2. DiLorenzo TP, Serreze DV: The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol Rev 204:250-263, 2005
3. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr.: CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183:67-76, 1996
4. Nagata M, Santamaria P, Kawamura T, Utsugi T, Yoon JW: Evidence for the role of CD8 + cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol 152:2042-2050, 1994
5. Graser RT, DiLorenzo TP, Wang F, Christianson GJ, Chapman HD, Roopenian DC, Nathenson SG, Serreze DV: Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 164:3913-3918, 2000
6. Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P: Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406:739-742, 2000
7. DiLorenzo TP, Lieberman SM, Takaki T, Honda S, Chapman HD, Santama-ria P, Serreze DV, Nathenson SG: During the early prediabetic period in NOD mice, the pathogenic CD8(+ ) T-cell population comprises multiple antigenic specificities. Clin Immunol 105:332-341, 2002
8. Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, Finegood DT, Santamaria P, Tan R: Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111:217-223, 2003
9. Krishnamurthy B, Dudek NL, McKenzie MD, Purcell AW, Brooks AG, Gellert S, Colman PG, Harrison LC, Lew AM, Thomas HE, Kay TW: Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 116:3258-3265, 2006
10. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS: Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220-223, 2005
11. Nakayama M, Beilke JN, Jasinski JM, Kobayashi M, Miao D, Li M, Coulombe MG, Liu E, Elliott JF, Gill RG, Eisenbarth GS: Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest 117:1835-1843, 2007
12. Daniel D, Gill RG, Schloot N, Wegmann D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062, 1995
13. Daniel D, Wegmann DR: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93:956-960, 1996
14. Toma A, Haddouk S, Briand JP, Camoin L, Gahery H, Connan F, Dubois-Laforgue D, Caillat-Zucman S, Guillet JG, Carel JC, Muller S, Choppin J, Boitard C: Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci USA 102:10581-10586, 2005
15. Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C: Recognition of HLA class I-restricted β-cell epitopes in type 1 diabetes. Diabetes 55:3068-3074, 2006
16. Standifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, Green-baum CJ, Pihoker C, Nepom GT: Identification of novel HLA-Az.ast;0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes 55:3061-3067, 2006
17. Blancou P, Mallone R, Martinuzzi E, Severe S, Pogu S, Novelli G, Bruno G, Charbonnel B, Dolz M, Chaillous L, van Endert P, Bach JM: Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients. J Immunol 178:7458-7466, 2007
18. + T-Cell responses identify β-cell autoimmunity in human type 1 diabetes. Diabetes 56:613-621, 2007
19. Martinuzzi E, Lemonnier FA, Boitard C, Mallone R: Measurement of CD8+ T-cell responses in human type 1 diabetes. Ann N Y Acad Sci. In press
20. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA: Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346:1692-1698, 2002
21. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De BC, Seigneurin JM, De PP, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L: Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598-2608, 2005
22. Brooks-Worrell BM, Starkebaum GA, Greenbaum C, Palmer JP: Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J Immunol 157:5668-5674, 1996
23. Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC: Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 55:2588-2594, 2006
24. Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW: Autoreactive T cells in healthy individuals. J Immunol 172:5967-5972, 2004
25. Yang J, Danke NA, Berger D, Reichstetter S, Reijonen H, Greenbaum C, Pihoker C, James EA, Kwok WW: Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J Immunol 176:2781-2789, 2006
26. Viglietta V, Kent SC, Orban T, Hafler DA: GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 109:895-903, 2002
27. Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M: Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 113:451-463, 2004
28. Monti P, Scirpoli M, Rigamonti A, Mayr A, Jaeger A, Bonfanti R, Chiumello G, Ziegler AG, Bonifacio E: Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol 179:5785-5792, 2007
29. Martinuzzi E, Scotto M, Enée E, Ribeil JA, van Endert P, Mallone R: Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection. J Immunol Methods. January 29 2008 [Epub ahead of print]
30. Hassainya Y, Garcia-Pons F, Kratzer R, Lindo V, Greer F, Lemonnier FA, Niedermann G, van Endert PM: Identification of naturally processed HLA-A2 restricted proinsulin epitopes by reverse immunology. Diabetes 54:2053-2059, 2005
31. Takaki T, Marron MP, Mathews CE, Guttmann ST, Bottino R, Trucco M, DiLorenzo TP, Serreze DV: HLA-Az.ast;0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol 176:3257-3265, 2006
32. van Endert P, Hassainya Y, Lindo V, Bach JM, Blancou P, Lemonnier F, Mallone R: HLA class I epitope discovery in type 1 diabetes. Ann NY Acad Sci 1079:190-197, 2006
33. American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 29 (Suppl. 1):S43-S48, 2006
34. Bingley PJ, Bonifacio E, Mueller PW: Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 52:1128-1136, 2003
35. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R: Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2205-2213, 1998
36. Monsurro V, Wang E, Yamano Y, Migueles SA, Panelli MC, Smith K, Nagorsen D, Connors M, Jacobson S, Marincola FM: Quiescent phenotype of tumor-specific CD8+ T cells following immunization. Blood 104:1970-1978, 2004
37. Nepom GT, Lippolis JD, White FM, Masewicz S, Marto JA, Herman A, Luckey CJ, Falk B, Shabanowitz J, Hunt DF, Engelhard VH, Nepom BS: Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad SciUSA98:1763-1768, 2001
38. Mallone R, Kochik SA, Laughlin EM, Gersuk VH, Reijonen H, Kwok WW, Nepom GT: Differential recognition and activation thresholds in human autoreactive GAD-specific T-Cells. Diabetes 53:971-977, 2004
39. Peakman M, Stevens EJ, Lohmann T, Narendran P, Dromey J, Alexander A, Tomlinson AJ, Trucco M, Gorga JC, Chicz RM: Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest 104:1449-1457, 1999
40. Jaeckel E, Klein L, Martin-Orozco N, Von BH: Normal incidence ofdiabetes in NOD mice tolerant to glutamic acid decarboxylase. J Exp Med 197:1635-1644, 2003
41. Yamamoto T, Yamato E, Tashiro F, Sato T, Noso S, Ikegami H, Tamura S, Yanagawa Y, Miyazaki JI: Development of autoimmune diabetes in glu-tamic acid decarboxylase 65 (GAD65) knockout NOD mice. Diabetologia 47:221-224, 2003
42. Kubosaki A, Nakamura S, Notkins AL: Dense core vesicle proteins IA-2 and IA-2beta: metabolic alterations in double knockout mice. Diabetes 54 (Suppl. 2):S46-S51, 2005
43. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B: International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 50:2451-2458, 2001
44. Wicker LS, Chen SL, Nepom GT, Elliott JF, Freed DC, Bansal A, Zheng S, Herman A, Lernmark A, Zaller DM, Peterson LB, Rothbard JB, Cummings R, Whiteley PJ: Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 98:2597-2603, 1996
45. Patel SD, Cope AP, Congia M, Chen TT, Kim E, Fugger L, Wherrett D, Sonderstrup-McDevitt G: Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(al-pha1z.ast;0101, beta1z.ast;0401) transgenic mice. Proc Natl Acad Sci USA 94:8082-8087, 1997
46. Honeyman MC, Stone NL, Harrison LC: T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavi-rus and other environmental agents. Mol Med 4:231-239, 1998
47. Watts C, Lanzavecchia A: Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 178:1459-1463, 1993
48. Reijonen H, Daniels TL, Lernmark A, Nepom GT: GAD65-specific autoan-tibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes 49:1621-1626, 2000
49. Bernasconi NL, Traggiai E, Lanzavecchia A: Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-2202, 2002
50. Prlic M, Williams MA, Bevan MJ: Requirements for CD8 T-cell priming, memory generation and maintenance. Curr Opin Immunol 19:315-319, 2007